(free thyroxine) andthemethod of Weeke and #{248}rskov (total thyroxine). The kit procedure permits determination of both freeand total thyroxinewithin4 to 5 h, and the combined results may disclose changes in binding to plasma proteins that would be missed if only free thyroxine were determined.
With both free-thyroxine methods, the values distinguished hyperthyroid patients from normal controls and pregnant women with 100% accuracy, but there was some overlap between hypothyroid patients and controls. Absolute values with the kit procedure often exceed those obtained by dialysis, especially for hypothyroid patients and pregnant women. We conclude that the kit may be of as much diagnostic value as the dialysis method if the limitations regarding absolute values are kept in mind and the test is not used as a substitute for thyrotropin determinations in cases of suspected hypothyroidism.
Additional Keyphrases:
"kit" methods thyroid status
Circulating thyroxine and triiodothyronine are mostly bound to plasma proteins, and it is generally admitted that the unbound ("free") fractions are more directly related to the metabolic state than is either the total or bound fraction (I, 2). Corning Medical, Medfield, MA 02052, has developed a method for determination of "free" thyroxine (F-T4) as a result of studies on the kinetics and thermodynamics of the binding of thyroxine to anti-T4 antibodies immobilized on glass particles (3) . These studies demonstrated that the rate at which thyroxine adsorbs onto the immobilized antibody is related to the amount of F-T4, the process being monitored with labeled thyroxine. The most adequate response "metameters"
for the calculation of F-T4 from the raw data obtained with the reagents supplied by Corning Medical have been discussed by Ekins (4) and have been taken into account by the manufacturers.
Here, we report an evaluation of the F-T4 kit supplied by Corning Medical.
We determined that F-T4 and total thyroxine (T-T4) with the kit and compared results with those obtained by other methods: a dialysis method for F-T4 (5) and a highly sensitive radioimmunoassay for T-T4 (6).
Materials and Methods
We used a total of 85 samples. None of the 20 healthy volunteers were taking oral contraceptives or had any clinical history of thyroid disease. Twenty samples were obtained from
patients who were clinically thyrotoxic and had high serum triiodothyronine concentrations, 25 from patients who where clinically hypothyroid and had higher than normal circulating thyrotropin concentrations, and 20 from pregnant women. The samples were collected at the Middlesex Hospital, London. Aliquots were used there to determine F-T4 by the dialysis procedure (5) . T-T and F-T4 were determined in Madrid with the kit reagents provided by Corning Medical, and T-T4 and total triiodothyronine (T-T;t) by previously validated methods (6, 7). The code for identification of the samples was broken after we received the data for the F-T4 determinations carried out at the Middlesex Hospital. The only plasma thyrotropin determinations were those done to confirm previous thyrotropin determinations used for initial diagnosis, and these were done after breaking the code.
In determining T-T4 and F-T4 concentrations by the kit procedure we used four of these kits for the 85 sera, the unknown samples being allotted at random to each kit. Some of the samples, also chosen at random, were run in several assays.
Briefly, the assay requires 25-zL aliquots of standards of unknowns, pipetted in quadruplicate; two tubes receive a solution containing '251-labeled thyroxine (the A series of tubes) and two the same solution except containing thimerosal as blocker of thyroxine binding to proteins (B series of tubes). After a 30-mm incubation, the anti-thyroxine antibody, immobilized on glass particles, is added. After 30 mm, the tubes are centrifuged and the supernates discarded.
The radioactivity of the A and B series of tubes (cpm A; cpm B) and of the total radioactivity added (cpmT) is determined by 1-mm counts in an automatic gamma counter.
The cpm B values for the standards are used to plot the T-T4 standard curve, with use of data supplied by the manufacturers (13, 52, 107, 210, and 315 nmol/L). The T-T4 value and the cpm A values of the standards are used to calculate the response "metameter" Y IY = (cpmA/cpmB) X T-T4, which is plotted against the F-T4 concentrations supplied by the manufacturers (6.4, 12.8, 25.7, 51.5, and 77.2 pmol/L) to obtain the F-T4 standard curve.
F-T4 was also determined by the dialysis procedure described by Ekins and Ellis (5). In brief, 200-L aliquots of sera are dialyzed overnight at 4 #{176}C against 5 mL of dialysismedium containing sodium azide (not thimerosal) as hacteriostat.
The thyroxine in the dialysate is then determined by radioimmunoassay.
T-T4 and T-T3 were also determined according to Weeke and Orskov (6, 7) , with minor modifications introduced by
Obregon (8), such as the use of polyethylene glycol instead of wick chromatography to separate free and antibody-bound labeled thyroxine. The very high specific activity of the labeled thyroxine and triiodothyronine obtained inthe laboratory (9, 10) allows the use of very small serum aliquots, namely 0.5 zL per tube and 10 tL per tube for T-T4 and T-T:t, respectively. The radioimmunoassay buffer contains 0.6 mmol of thimerosal, addition of other "blockers" being necessary for T-T4. For T-T:4,2.37nmol of 8-anilino-1-naphthalene sulfonic acid isadded as "blocker."
We used the kit from Corning Medical to determine serum 
Results
Using the reagents provided by Corning Medical, we found the radioactivities in duplicate tubes to be almost identical. The standard curves for F-T4 obtained with the four different kitswere almost superimposable. There was a somewhat larger variation in the T-T4 standard curves in the range corresponding to low T-T4 (52 nmol/L, and lower). Table 1 summarizes between-assay variations we obtained for the two control sera supplied, as well as for six unknown sera chosen at random. The CVs are quite satisfactory for the F-T4 and T-T4 values of the sera tested with the four kits, the two samples from hypothyroid patients excepted.1 Figure 1 shows results for T-T4 by both the kit method and the comparison method. Table 2 may he owing to differences in the T-T4 standard curves in the low T-T4 range; when we used cpm B/cpm T data obtained for each of the two hypothyroid sera on different occasions, the between-assay CVs were reduced to 1.8 and 2.9%. pleshaving a T-T4 near or above the upper limitof detection of the kit method. About 70% of the 20 sera from pregnant women had a T-T4 value exceeding 154 nmol/L with the kit method, whereas with the reference method only 40% exceeded the normal range.
The major difference between the results obtained by the two methods was for sera from hypothyroid patients. None of them had a T-T4 value above 77 nmol/L by the reference method, but with the kit procedure there was some degree of overlap with the normal range, four of 25 samples giving a T-T4 value above 77 nmol/L, though two of them did not exceed 90 nmol/L. Although in all groups except the hyperthyroid group the T4 value obtained with the kit procedure exceeded that with the reference method (Table 2) , the difference was particularly striking in the case of sera from hypothyroid patients.
These relationships are also illustrated in Figure 2 , where the individual T-T4 values obtained with both methods are plotted. This was the case for four sera with use of the kit procedure, one of them having a borderline value, and for six sera by the dialysis method. Three sera giving a F-T4 value within the normal range with the kit reagents were the same ones that also had a normal T-T4 and a normal F-T4 by the dialysis method. The data obtained with the Corning Medical procedure were higher than those by the dialysis method for all groups except the hyperthyroid one ( Table 2 ). The highest ratios were found for the sera from hypothyroid patients and pregnant
women. of Weeke and #{216}rskov (7), which support the stated diagnosis of the patients. So did the concentrations of thyrotropin in the plasma of the 17 pregnant women tested and of the 25 sera from hypothyroid patients.4
Discussion
The laboratory performance of the kit was quite satisfactory. The procedure is simple, and both the T-T4 and F-T4 of The standard curves for F-T4 and T-T4 obtained with different kits were very similar, except for T-T4 in the low range. This might be due to excessive spacing of the low T-T4 standards.5 Results obtained with the internal controlserasupplied by the manufacturers fell within the reported means ± 1 SD. Between-assay CVs were satisfactory for sera from normal and hyperthyroid patients, and pregnant women. CVs for the F-T4 of the two sera from hypothyroid patients could not be calculated and those for the T-T4 were higher (-.'20%),
With data on both F-T4 and T-T4, hyperthyroid patients can be identified and distinguishedwith 100% accuracy from normal people and pregnant women, both with the kit and the other methods we used. Diagnostic accuracy of the F-i'4 values was less for the group of 25 hypothyroid patients, both with the kit procedure (84%) and the dialysis method (76%), as already observed by others (11). Thus, from the present series .
_1
The lowest plasma thyrotropin value in the hypothyroid group (16 punits/mL), although well above the normal range given by the manufacturers (O.2-.9.1 punits/mL), corresponded to a patient with T-T4 (kit procedure) and F-i'4 (both the kit and the dialysis methods) (7) of patients,itwould appear that the kitmethod gives at least the same clinical information as that obtained by a well-established dialysis technique, but is simpler to perform, not requiring any more experience than is needed for other routine radioimmunoassays. However, the diagnostic performance of the T-T4 and T-T:t data, as obtained by the methods of Weeke and Orskov (6, 7) was 100%, even in the hypothyroid range. One of the normal controls might have been classified as hypothyroid, on the basis of the T-T4 value alone, but this diagnosis would have been excluded after determination of thyrotropin, which was normal. However, none of the hypothyroid patients would have been missed on the basis of the T-T4 or T-T:t data alone.
The absolute values obtained for F-T4 and for T-T4 concentrations depend on the method used; this is especially evident for sera from hypothyroid patients and pregnant women. Itis impossible at present to know which procedures, if any, give "true" results, i.e., results that represent the actual circulating F-T4 and T-T4 concentrations. As pointed out (4), none of the dialysis methods for F-T4 can be considered as having the status of a reference technique. A possible factor that might increase the F-T4 results in the case of the kit procedure and other procedures in which the patient's plasma proteins are present during the radioimmunoassay, is nonspecific binding of the labeled thyroxine tracer, which would be more prominent in sera with low F-T4 and a larger pro- Such a factor might also contribute to overestimation of the T-T4 in these groups, despite addition of a standard amount of thimerosal. 
